Cardiac myoblasts, integral to the cardiovascular system, play a vital role in the intricate dance of heart functionality. As specialized muscle cells, they contribute significantly to cardiac development during embryogenesis, intricately weaving the essential muscle fibers that form the foundation for effective blood pumping. Beyond their critical role in heart development, these cells are garnering attention in the realm of regenerative medicine. Researchers are actively exploring the potential of cardiac myoblasts to serve as a regenerative force, particularly in the repair of damaged heart tissue. The unique ability of cardiac myoblasts to mature into functional cardiac muscle cells positions them as a promising avenue for therapeutic interventions, with the potential to revolutionize approaches to treating cardiovascular diseases. Ongoing studies in this field hold the key to uncovering innovative strategies that could redefine the landscape of cardiac regenerative medicine.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation